Background: Recent discoveries from animal models demonstrated that neutrophils
is an autoimmune disease that occurs as the consequence of the destruction of pancreatic β cells mediated primarily by auto-reactive T cells, 1 increasing evidence shows that various other types of immune cells including neutrophils also play essential roles in the progression of the disease. 2, 3 In animal models, recent studies demonstrated that neutrophils might infiltrate in the pancreas of NOD mice in their early ages, and treatment with an anti-Ly6G antibody which can block the activities of neutrophils inhibited the development of insulitis and diabetes. 3 Further studies showed that pancreatic macrophages and β-cells which produce chemokines CXCL1 and CXCL2 can recruit CXCR2-expressing neutrophils to the pancreatic islets from the circulation. 4 Our previous studies discovered that circulating neutrophil serine proteases including neutrophil elastase and proteinase 3
increased significantly in patients with T1D and were closely associated with β-cell autoimmunity, suggesting a role of neutrophil activation in the onset and pathogenesis of the disease. 5 It is known that LADA is a form of autoimmune diabetes with features of both type 1 and type 2 diabetes and lies in the middle of the diabetes spectrum. 6, 7 Until now, it is not understood why the disease has a slower progression toward insulin dependent than T1D. To our knowledge, the role of neutrophils in the disease development has not been reported yet. Moreover, there is no information of the neutrophil presence and activity change trend in diabetes spectrum including T1D, LADA and type 2 diabetes. In this study, we focused on patients with newly diagnosed T1D, LADA, type 2 diabetes, and their sex-matched and age-matched healthy subjects, with the aim to explore neutrophil counts, neutrophil functions, and the potential roles of chemokine receptors and adhesion molecules in the development of these diseases. 
| MATERIALS AND METHODS

| Subjects
| Clinical and biochemical assessments
Clinical and biochemical indexes were evaluated on each patient at the study site of the Second Xiangya Hospital. Blood specimens were collected around 0800 h after overnight fasting, or 60 and 120 minutes after the mixed meal, and were processed immediately for the biochemical analysis. Circulating cell counts were measured by the Sysmex XE-2100 automated haematology analyser. Plasma glucose was analysed by a Hitachi 7170 analyser (Boehringer Mannheim, Germany). Serum levels of C-peptide were measured by fasting and 2 hours postprandial plasma glucose using Adiva Centaur System.
Titres of autoantibodies of GAD, IA2, and ZnT8 were analysed by radio ligand assays in duplicate as previously described. 8, 9 The sensitivity of GADA, IA-2A, and ZnT8A assays were 78%, 74%, and 70%, respectively, and the specificity of these assays were 96.7%, 96.7%
and 98.9%, respectively, in the Islet Autoantibody Standardization
Program (IASP2012). Glycosylated haemoglobin (HbA1c) was quantified by liquid chromatography using Bio-Rad VARIANT II Haemoglobin
Testing System.
| Neutrophil isolation and flow cytometry
Human neutrophils were isolated from venous blood of patients and healthy subjects by Ficoll-Paque Plus gradient centrifugation and positive magnetic separation for further purification by using human CD16 Microbeads (Miltenyi Biotec). Cells were stained with various monoclonal antibodies CXCR1, CXCR2, CD62L, CD11a, CD11b, and CD49d (BioLegend) and were analysed on a FACSCalibur 
| Trans-well migration assay
Neutrophils were resuspended at a concentration of 5 × 10 6 cell/mL in RPMI medium containing 1% bovine serum albumin. Cells were incubated with Calcein AM (Sigma-Aldrich, USA) for 10 minutes at room temperature and washed. The labelled cells were added into a 5-μm pore bare filter insert that were placed on the top of wells containing 100 ng/mL IL-8, or directly added into wells without the filter insert.
After 1 hour of incubation at 37°C in 5% CO2 humidified environment, transwell was removed from the plate, and cells in the bottom wells were lysed with 1% Triton X-100. The number of neutrophils that migrated into the bottom wells was determined by using a Thermo Scientific Microplate Reader. Neutrophil migration rate was expressed as the number of cells migrating to the bottom wells relative to total neutrophil numbers. One-way ANOVA was used for comparisons among groups.
| Neutrophil phagocytosis assay
Correlations were described with Pearson correlation or Spearman correlation as appropriate. In all statistical comparisons, P < 0.05 was considered significant.
3 | RESULTS
| Subject characteristics
Characteristics of subjects with newly diagnosed T1D (n = 189), LADA (n = 86), type 2 diabetes (n = 235), and their respective age-matched and sex-matched controls are described in Table 1 . Type 1 diabetes patients were younger than both of LADA patients and type 2 diabetes patients (both P < 0.001). Patients with type 2 diabetes had higher body mass index (BMI) than the control group and showed the characteristics of abdominal obesity indicated by increased waist circumference values (both P < 0.001), while patients with T1D had lower BMI than their healthy controls (P < 0.001). As expected, the median of fasting C peptide, 1 and 2 hours postprandial C peptide were different. The levels of C peptide increased gradually from T1D, LADA to type 2 diabetes (P < 0.05 for global trend).
| Comparison of leukocyte and neutrophil counts in different types of diabetes
Circulating counts of white blood cell (WBC), neutrophil, and lymphocyte were different among groups ( Figure 1A ,B,C; all P < 0.05), though comprehensive overlaps existing between groups. Type 2 diabetes patients had increased levels of WBC and neutrophil when compared with patients with T1D and LADA ( Figure 1A ,B, P < 0.001). Type 1 diabetes patients showed lower neutrophil counts than those with LADA ( Figure 1B , P < 0.01). Therefore, neutrophil counts in LADA patients displayed a trend to be lower than type 2 diabetes patients, but higher than those with T1D. The differences remained significant after adjustment for age, gender, BMI, and blood pressure. Compared with age-matched and gender-matched controls, patients with T1D presented lower numbers of WBC and neutrophils, while patients with type 2 diabetes showed higher ones ( Figure 1D ,E, both P < 0.05).
Although no difference was found in WBC and neutrophil between LADA patients and their matched controls ( Figure 1D ,E, P > 0.05), patients diagnosed with LADA had higher numbers of lymphocytes than their controls ( Figure 1F , P < 0.05).
3.3 | Associations of neutrophil counts with metabolic parameters, C-peptide, and β-cell specific autoimmunity
Circulating WBC and neutrophil counts were positively correlated with age, BMI, and systolic blood pressure (Table 2, 
| Alterations of neutrophil migration and phagocytosis in different types of diabetes
Among these patients, neutrophils were isolated from 23 patients with T1D, 18 patients with LADA, 27 patients with type 2 diabetes, and 50 controls. Neutrophil phagocytic rate in patients with T1D was the same as that in patients with LADA and type 2 diabetes ( Figure 3A , P > 0.05). No significant differences were found in neutrophil phagocytic rate between patients with diabetes and their healthy controls, either ( Figure 3B , P > 0.05). However, neutrophil migration rate in patients with T1D and LADA were lower than that in patients with type 2 diabetes ( Figure 3C , both P < 0.05), independent of age, gender, and BMI. Compared with the controls, T1D patients showed decreased neutrophil migration rate ( Figure 3D , P = 0.002). In addition, LADA patients also presented reduced neutrophil migration rate ( Figure 3D , P = 0.008). Further analysis showed that neutrophil migration rate in patients with T1D were closely correlated with levels of fasting C-peptide (Table 3 , P < 0.05).
| Alterations of chemokine receptors and adhesion molecules expressed on neutrophils
Patients with diabetes showed similar expression of CXCR1 and CXCR2 to their controls ( Figure 4A ,B, both P > 0.05). For adhesion molecules, CD11b expression in type 2 diabetes was higher than that in the controls ( Figure 4C , both P < 0.05). Similar levels of CD11a and CD49d were found in diabetes patients and healthy controls ( Figure 4D ,E, both P > 0.05). CD62L expression in T1D was significantly increased compared with healthy controls ( Figure 4F , P = 0.003), type 2 diabetes patients ( Figure 4F , P = 0.020) and LADA patients ( Figure 4F , P = 0.026). Moreover, CD62L expression in T1D
was positively associated with IA-2A titre (Table 4 , P = 0.001), and inversely correlated with neutrophil migration rate ( Table 4 , P = 0.019). Our RNA-seq analysis also showed that CD62L expression was increased on neutrophils of T1D patients when compared with healthy controls ( Figure 5 ). However, the expression of intercellular cell adhesion molecule-1, tumour necrosis factor, IL-6, as well as neutrophil chemokines CXCL8, CXCL1, CXCL2, CXCL3, and CXCL16
were decreased in neutrophils of T1D patients ( Figure 5 ).
| DISCUSSION
In this study, we observed that T1D patients had decreased neutrophil counts, while subjects with type 2 diabetes showed increased Recent studies from our lab and our collaborators demonstrated that circulating neutrophil serine proteases including neutrophil elastase and proteinase 3 increased significantly in T1D patients. 5 The elevated levels were associated with positive autoantibody titres, suggesting a role of neutrophil activation in the onset and pathogenesis of β-cell autoimmunity in T1D. 5 LADA is a slowly progressive form of autoimmune-mediated diabetes which has differences from either classic T1D or type 2 diabetes but also shares some clinical and immuno-genetic features with these two types of diabetes. [10] [11] [12] Different ethnic populations show heterogeneity in the prevalence and other characteristics of LADA because of the differences in dietary habits, environmental factors, and phenotypic characteristics. 11, 12 Similar to insulin secretion, neutrophil counts in LADA patients were found to be higher than patients with T1D, both lower than type 2 diabetes patients in our present study. The traits of LADA patients in our study are consistent with previous studies from different countries, [13] [14] [15] [16] which showed that patients with LADA have distinct clinical characteristics when compared with T1D or T2D patients. In these studies, LADA patients were found to be leaner and younger than subjects with type 2 diabetes. The level of fasting C-peptide and frequency of metabolic syndrome of these patients were lower than T2D patients but higher than subjects with T1D.
Titres of autoantibodies, especially GADA, are related to beta cell function. With respect to type 2 diabetes, it was reported that neutrophil proteinase 3 can induce type 2 diabetes by connecting inflammation via down-regulation of insulin-like growth factor and insulin-like growth factor-binding protein-3 levels, which are different from the role in T1D. 17 Moreover, growing evidence demonstrated that the level of neutrophil number has a link with insulin sensitivity, 18 incidence of type 2 diabetes, and metabolic syndrome. 19 Raised neutrophils can infiltrate adipose tissue and have an essential effect in insulin resistance. 20 But neither neutrophil nor other leukocyte infiltration was found in the pancreas of patients with type 2 diabetes. 21 Therefore, it seems that neutrophils might cause an indirect pancreatic β-cell damage in the development of type 2 diabetes, not the same mechanism as that in T1D. In our study, although type 2 diabetes patients showed the same neutrophil migration and phagocytosis ability as the controls, neutrophil numbers in patients with diabetes FIGURE 1 Circulating leukocyte number in patients with type 1 diabetes, LADA, type 2 diabetes, and their healthy controls. Circulating leukocyte number in patients with newly diagnosed diabetes: A, white blood cell (WBC); B, neutrophil; C, lymphocyte, and circulating leukocyte number in patients with type 1 diabetes, LADA, type 2 diabetes, and their age-matched and gender-matched healthy controls, respectively; D, WBC; E, neutrophil; F, lymphocyte. Each point represents the measured leukocyte number of an individual. Horizontal lines depict means. * P < 0.05; ** P < 0.01; *** P < 0.001 Abbreviations; BMI, body mass index: HDL, high-density lipoprotein; LDL, low-density lipoprotein.
*P < 0.05; **P < 0.01; ***P < 0.001.
including type 2 diabetes were closely associated with the levels of fasting C peptide, 1 and 2 hours postprandial C peptide.
Consistent with our findings, reduced circulating neutrophil numbers were also observed in T1D patients. 22, 23 Decreased counts of blood neutrophils could be the results of abnormal neutrophil yield and maturation, peripheral consumption or damage, and/or tissue detainment. 24 It was considered that neutrophils accumulated in the pancreas might account for the reduced blood neutrophils in T1D
patients. 23 As we have known, the ability of neutrophils to migrate effectively is critical to bring cells into target tissue from the 
FIGURE 3
Neutrophil phagocytosis and migration in patients with type 1 diabetes (T1D, n = 23), latent autoimmune diabetes in adults (LADA, n = 18), type 2 diabetes (T2D, n = 27), and their controls (n = 50). Neutrophil phagocytic rate in patients with T1D, LADA, T2D (A) and in patients as well as their respective controls (B). Neutrophil migration rate in patients with T1D, LADA, T2D (C) and in patients and their healthy controls as well (D). * P < 0.05; ** P < 0.01; *** P < 0.001
bloodstream. However, in our study, we discovered that neutrophil migration rate decreased in T1D patients when compared with their healthy controls and patients with type 2 diabetes. As pancreatic macrophages and β-cells play essential roles in recruiting CXCR2-expressing neutrophils from the blood to the pancreatic islets 4 and β-cell mass is usually reduced by 70% to 80% at the time of diagnosis in T1D, 25 it is reasonable that neutrophil migration decreased gradually with the development of the disease. Therefore, reduced circulating neutrophil numbers might be associated with other factors. It is possible that augmented neutrophil death can lead to increased consumption of 
FIGURE 4
Chemokine receptors and adhesion molecules expressed on neutrophils in patients with type 1 diabetes (T1D, n = 23), latent autoimmune diabetes in adults (LADA, n = 18), type 2 diabetes (T2D, n = 27), and their controls (n = 50). A, CXCR1; B, CXCR2; C, CD11b; D, CD11a; E, CD49d; F, CD62L. * P < 0.05; ** P < 0.01; *** P < 0.001 peripheral neutrophils. Our previous study demonstrated that increased NETosis may partially contribute to reduced circulating neutrophils in T1D. 5 In addition, it was reported that the response of haematopoietic stem cell from patients with diabetes to granulocytecolony stimulating factor was poorer than that in patients without diabetes. 26 Moreover, findings from animal models proved a defect in the bone marrow microenvironment, and it was suggested that neutrophils were impaired in their egression from the bone marrow in diabetes. 26 However, whether the reduction of neutrophil production occurs in T1D or not remains unclear. Future studies from both humans and animal models are required to explore the neutrophil production and elucidate the specific reasons for decreased circulating neutrophil numbers in T1D.
It was recorded that neutrophil migration can be regulated by chemotactic responses induced by interactions of chemo-attractants and their specific receptors. In this study, we detected that CD62L from neutrophils increased in T1D patients and was closely related with neutrophil migration and IA-2A titre. Various studies have
shown that augmented soluble L-selectin level (also known as CD62L) remarkably associated with high titre of IA-2A in patients with T1D and subjects in the preclinical stage of the disease. [27] [28] [29] Therefore, soluble CD62L expression was considered to manifest an active destructive insulitis procedure. It is known that CD62L can be released from various immune cells 30 and is rapidly effluxed from neutrophils after their activation. 31 To the best of our knowledge, our study is the first to demonstrate that CD62L expression in neutrophils increased and was closely associated with IA2A titre in patients with newly diagnosed T1D. Moreover, its expression was highly associated with neutrophil migration, suggesting that CD62L exert an essential effect on the migration of neutrophil from blood into pancreatic islet and the occurrence of β-cell autoimmunity. Increased expression of CD62L should be associated with increased migration, while in the present study we found the opposite. The discrepancy might be due to the fact that many other factors can affect the process of neutrophil migration. Previous studies indicated that tumour necrosis factor, intercellular cell adhesion molecule-1, and IL-6 can play a positive role in neutrophil migration. [32] [33] [34] In this study, our RNA-Seq analysis showed that the expression of these genes as well as neutrophils chemo-attractants including CXCL8, CXCL1, CXCL2, CXCL3, and CXCL16 were decreased in T1D patients when compared with healthy controls. Therefore, many other molecules in addition to CD62L may act together to mediate neutrophil migration. But whether CD62L function is impaired or not needs to be further investigated.
There are several limitations in our study. Firstly, we did not fully exclude bias by confounding factors like smoking, which was considered to affect neutrophil number in the circulation. Therefore, our future studies should take this variable into consideration. Secondly, due to the relatively small sample size for LADA patients and the cross-sectional design, future large-scale and longitudinal studies are needed to clarify the alterations and dynamic changes of the circulating neutrophil counts in diabetes patients and to further investigate their concrete roles in the pathogenesis of different types of diabetes.
Taken together, we demonstrated for the first time that neutrophil counts increased progressively from T1D, LADA to type 2 diabetes, suggesting a differential role of neutrophil in different types of diabetes. We also found impaired migration ability of neutrophils in 
